Results for national advisory committee immunization

Add to feed Create your own feed

Latest

Hesitancy around AstraZeneca was further inflamed last week after the National Advisory Committee on Immunization repeated its recommendation that mRNA vaccines such as Pfizer and Moderna are “preferred” over viral vector vaccines such as AstraZeneca. /6

tweet picture

Although Health Canada has just authorized the vaccine for use in younger populations, the National Advisory Committee on Immunization had already recommended last month that the dose could be given to teens at high risk of contracting the disease

“The recommendation is not a retrospective one" - The chair of the National Advisory Committee on Immunization says people who already got the Oxford-AstraZeneca vaccine should not feel they made a bad choice.

The chair of the National Advisory Committee on Immunization says people who already got the Oxford-AstraZeneca vaccine should not feel they made a bad choice.

The chair of the National Advisory Committee on Immunization says people who already got the Oxford-AstraZeneca vaccine should not feel they made a bad choice

tweet picture

#Opinion : With one blow, the National Advisory Committee on Immunization (NACI) dealt a serious setback to all the advice the government has been dispensing to Canadians on getting the first shot available to them @SusanDelacourt  writes.

Comments about “preferred” vaccines from the National Advisory Committee on Immunization have caused confusion among Canadians, who were told for months that the best vaccine is the one you can get first. At 9:30am, @SabiVM  helps clear up that confusion

The National Advisory Committee on Immunization is coming under fire after contradicting the advice Canadians have been receiving for weeks to take the first vaccine against COVID-19 that they’re offered

tweet picture

NEW: the National Advisory Committee on Immunization has been asked for recommendation by mid-May on Pfizer or Moderna as 2nd shot to people who got AstraZeneca first, given short supplies of AZ at this point, says Ontario assoc med officer Dr. Barbara Yaffe. #onpoli 

Should the doses be cleared for use, the National Advisory Committee on Immunization said that adults aged 30 and older should be prioritized to receive them.

Loading
Loading

Most relevant

Time and again, many doctors and politicians have been saying: Best vaccine you can get is the first one offered to you. Today, the doctors on the National Advisory Committee on Immunization say: If you can wait for Pfizer and Moderna, best to do so.

Use of AstraZeneca's COVID-19 vaccine recommended for use in people aged 30 and up. National Advisory Committee on Immunization says benefits of the vaccine outweigh the risks. Previous story for context:

BREAKING: The National Advisory Committee on Immunization now recommends provinces give the Astra Zeneca vaccine to adults 30 years of age and older #cdnpoli 

#BREAKING : The National Advisory Committee on Immunization now recommends provinces give the AstraZeneca COVID-19 vaccine to adults 30 years of age and older.

New recommendation from the National Advisory Committee on Immunization: AstraZeneca can be used in people 30+

National Advisory Committee on Immunization updates guidelines on AstraZeneca COVID-19 vaccine, says use in adults aged 55 and less should be paused for additional risk assessment; follows reports of heightened instances of blood clots in Europe.

CBC News has learned the National Advisory Committee on Immunization is recommending a pause on AstraZeneca vaccinations for people under 55 for safety reasons. New guidance is expected to be issued today. 1.5M doses of AstraZeneca are due to arrive from the U.S. tomorrow.

BREAKING: Canada's National Advisory Committee on Immunization will recommend pausing administration of the AstraZeneca coronavirus vaccine to those under the age of 55, a senior government source tells @CTVNews .

CBC News has learned the National Advisory Committee on Immunization is recommending a pause on AstraZeneca vaccinations for people under 55 for safety reasons. New guidance expected today. 1.5-million doses of AstraZeneca due to arrive from the United States tomorrow.

Loading
Loading